# Kromek Group Good visibility over future revenues

- Link: https://www.directorstalkinterviews.com/kromek-group-good-visibility-over-future-revenues/412816857
- Published: 2020-05-01T07:18:42+01:00
- Author: Giles Arbor

**Kromek Group plc** ([LON:KMK](https://www.directorstalkinterviews.com/company/kromek-group-plc/kmk.l)),
a worldwide supplier of detection technology focusing on the medical, security screening
and nuclear markets, today provided an update on trading for the 12-month period
ended 30 April 2020 and its business response to COVID-19.

**FY 2019/20 Trading Update**

As previously announced in its interim results on 11 December 2019, Kromek started
the second half of the financial year 2019/2020 with increasing commercial momentum
and delivering on multi-year contracts won over the previous three years. Until 
the end of February 2020, the Group did not experience any material impact on its
businesses as a result of the COVID-19 outbreak. However, in the subsequent two 
months, it has experienced a delay in certain projects due to constraints imposed
upon sub-contractors, suppliers and customers. Also, it has been informed that two
of its key contracts will now be postponed to the new financial year. As a result,
Kromek expects to report revenues of £14.5m, similar to FY 2018/2019 revenues, and
adjusted EBITDA is expected to be breakeven. The Group will continue to deliver 
on its multi-year contracts, which give it good visibility over future revenues,
and it has a healthy pipeline of projects. At 30 April 2020, the Group had a robust
balance sheet and cash of approximately £10m, including £3m utilised under its revolving
credit facility due for renewal in 2024 as well as a £2m five-year term-loan.

**Response to COVID-19**

In the middle of March 2020, Kromek activated its business continuity plan in response
to the COVID-19 outbreak. In order to protect the health and safety of its workforce,
some of the Group’s employees in the UK and US were transitioned to remote working.
Kromek uses virtualised applications and storage on the cloud, which has enabled
easier remote working and therefore there has been no significant reduction in the
Group’s delivery capability for clients. Sales and marketing activities have also
adapted to current market conditions.

Furthermore, a number of temporary mitigation measures have been implemented to 
bolster the liquidity of the business and its financial position. Actions taken 
include the implementation of some organisational restructuring; ceasing all discretionary
capital expenditure; curtailing all travel and non-essential spend; and, securing
a short-term rent concession on the Group’s leased properties. These measures, along
with others in the pipeline, are expected to reduce monthly running costs and cash
outflow, generating annualised savings of approximately £3m.

The Group also leveraged its technical and manufacturing skills in response to increased
demand for sophisticated medical equipment such as ventilators. It formed a partnership
with Metran Co., Ltd. to commence manufacture and sale of medical ventilators in
the UK and globally. Kromek is receiving significant interest in the ventilators
from potential customers in Europe and worldwide, and it is on track to produce 
at least 2,000 units by the end of July 2020.

**Outlook**

Given the evolving nature of the pandemic and the uncertainty over its length and
severity, Kromek Group is working diligently to assess, plan for and mitigate the
potential impact on its core markets by using its technical and manufacturing skills
to procure other opportunities in the short-term. As a result, the Group is unable
to provide accurate market guidance for FY 2020/2021. The fundamentals of the business
remain sound, and the Board is confident in the Group’s ability to withstand the
current situation, maximise the short-term opportunities and deliver on its long-
term growth ambitions. 

Share on:
